0 client engaged on account was roche pharmaceuticals, working with scientists to accelerate drug discovery and development for alzheimer's disease (gantenerumab molecule
0 client-specific engagement details withheld due to nda in place
0 gradual adoption of lightweight planning and methods of work visualisation
0 identification and recommendations for addressing systemic bottlenecks in working practices
0 localised acceleration of clinical development work, supporting evidence-based decision-making through an experiment-led approach